Host populations, challenges, and commercialization of cryptococcal vaccines
Vaccines are one of the most effective public health tools to prevent and manage infectious diseases. Since the first clinical use of vaccines in the late 18th century, many vaccines have been successfully developed to combat bacterial and viral infections, including the most recent Coronavirus Dise...
Main Authors: | Maurizio Del Poeta, Floyd L. Wormley, Xiaorong Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-02-01
|
Series: | PLoS Pathogens |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910758/?tool=EBI |
Similar Items
-
Host populations, challenges, and commercialization of cryptococcal vaccines.
by: Maurizio Del Poeta, et al.
Published: (2023-02-01) -
Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1
by: Tyler G. Normile, et al.
Published: (2022-05-01) -
Cryptococcus neoformans Δsgl1 Vaccination Requires Either CD4+ or CD8+ T Cells for Complete Host Protection
by: Tyler G. Normile, et al.
Published: (2021-09-01) -
New insights on the development of fungal vaccines: from immunity to recent challenges
by: Natasha P Medici, et al.
Published: (2015-01-01) -
Pulmonary cryptococcosis with cryptococcal meningitis in an immunocompetent host
by: Manoj Kumar Panigrahi, et al.
Published: (2014-01-01)